EliseAI's $4 billion valuation tracks a doubling in recurring revenue

If Crypto Briefing's revenue figures are right, the price per dollar of sales barely moved. The outlet said EliseAI passed $100 million of annual recurring revenue earlier in 2025 and $200 million by mid-2026 ^[9]. The Series E that closed in August 2025 ^[10] at $2.2 billion ^[4] comes to about 22 times the first figure ^[1]. The new $4 billion is about 20 times the second ^[2]. The valuation rose about 82% ^[3] while recurring revenue roughly doubled ^[8], so the returning co-leads paid slightly less per dollar of revenue this time than last.

Both revenue numbers are floors, so both multiples are ceilings. The comparison holds only if revenue at each round sat near the reported mark. The company's account to Fortune does not include revenue, or say whether $4 billion is the pre- or post-money figure. Crypto Briefing also put total capital raised at $380 million to $420 million ^[13]. Yet its own Series D of $75 million ^[11], plus the Series E and this round, sum to $675 million ^[7]. At least one figure in that report is stale, and the multiples above come from the same report.

Nobody sold. The round was all primary, with no secondary sale for early investors or employees, and nearly all major existing investors joined, according to Song ^[5]. Andreessen Horowitz and Bessemer have now funded the company four times since 2023 ^[2]. "They've really been up close and personal with our company over the last year and decided to double down on what we're building," Song told Fortune ^[6]. A returning lead that sets a higher price also lifts the marks on its own stake. Ontario Teachers' Pension Plan, the one new co-lead ^[3], is the buyer testing $4 billion from outside. If $4 billion is post-money, the new shares are about 8.75% of the company ^[4], against about 11.4% sold in the Series E ^[5].

The cash goes to product and to engineering, deployment and sales teams across North America, plus a second engineering hub in San Francisco ^[8]. Headcount went from about 150 after the Series D to more than 300 by mid-2025, Crypto Briefing reported ^[12]. Two rounds in 13 months have brought in $600 million of primary capital ^[6].

If recurring revenue doubles again, the same $4 billion becomes half today's multiple, and this round will look cheap in hindsight. If growth slows as the company pushes further into healthcare ^[14], about 20 times becomes the bar the next round has to clear with no help from a richer multiple. And if revenue at the Series E was well above $100 million, that round cost less than 22 times and the insiders did pay up this time. Song put the jump down to execution. "We've really expanded within the industries that we serve, housing and healthcare," she said ^[7].

I think the insiders bought a larger company at roughly the old price, and the step-up in valuation is the revenue growth carried through. The third case would prove that wrong. A revenue figure from EliseAI itself would show which case holds.